|
시장보고서
상품코드
1786981
세계의 펩티드 치료제 시장 규모, 점유율, 동향, 산업 분석 리포트 : 유형별, 제조업체별, 투여 경로별, 합성 기술별, 용도별, 지역별 - 시장 예측(2025-2034년)Peptide Therapeutics Market Size, Share, Trends, & Industry Analysis Report By Type (Generic and Innovative), By Type of Manufacturers, By Route of Administration, By Synthesis Technology, By Application, and By Region - Market Forecast, 2025-2034 |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
Polaris Market Research의 최신 조사에 따르면 세계의 펩티드 치료제 시장 규모는 2034년까지 3,133억 3,000만 달러에 달할 전망입니다. 이 리포트는 현재 시장 역학에 대한 상세 인사이트와 향후 시장 성장에 관한 분석을 제공하고 있습니다.
펩티드 치료제 시장은 제약사 및 생명공학 기업이 안정성, 생체 이용률, 전달 메커니즘을 개선한 첨단 제제를 개발함에 따라 진화하고 있습니다. 펩티드 합성 기술과 고체상 제조 공정의 개선이 진행되어 제조비용이 낮아지고 제제 선택의 폭이 넓어지고 있습니다.
또한 규제 당국은 지원적 프레임워크를 통해 신규 펩티드 의약품의 승인을 촉진하여 시장 성장을 더욱 가속화하고 있습니다. 임상 파이프라인의 펩티드 기반 제품 포트폴리오가 증가하고 상업화 활동이 활발해지면서 암, 대사성 질환, 감염성 질환, 희귀질환 등 다양한 치료 분야에서 시장 확대가 이루어지고 있습니다.
펩티드 치료제 시장 보고서 하이라이트
유형별로는 신약 부문이 우수한 약리학적 특성과 종양학, 대사성 질환, 희귀질환 등 난치성 질환 치료에서 입증된 효과로 인해 2024년 매출 점유율 1위로 부상할 것으로 예측되었습니다.
제조업체 유형별로는 생명공학 기업 및 전문 개발 기업이 CDMO와의 제휴를 늘리면서 외주 부문이 성장세를 보이고 있습니다.
투여 경로별로는 비경구 경로가 2024년 가장 큰 매출 점유율을 차지하며 펩티드 기반 치료에 가장 선호되는 전달 방법의 지위를 유지할 것으로 예측됩니다.
북미는 최첨단 의료 인프라, 탄탄한 연구 역량, 종합적인 의료 상환 프레임워크를 보유하고 있으며, 2024년 펩티드 치료제 세계 시장에서 60.21%의 압도적인 점유율을 차지할 것으로 예측됩니다.
아시아태평양 펩티드 치료제 시장은 예측 기간 중 가장 빠른 CAGR을 나타낼 것으로 예측됩니다. 이는 바이오의약품 혁신에 대한 정부의 지원이 증가하고 국내 의약품 개발에 대한 투자가 증가하고 있기 때문입니다.
세계의 주요 시장 기업에는 Advanced Accelerator Applications SA, AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, Bracco Imaging S.p.A., Cardinal Health, Inc., Curium Pharma, Eckert &Ziegler SE, F. Hoffmann-La Roche Ltd., GE HealthCare Technologies Inc., GlaxoSmithKline plc(GSK plc), Jubilant Radiopharma Limited, Lantheus Holdings, Inc., Eli Lilly and Company, Mallinckrodt plc 등이 있습니다.
목차
제1장 서론
제2장 개요
제3장 조사 방법
제4장 세계의 펩티드 치료제 시장 인사이트
- 시장 스냅숏
- 펩티드 치료제 시장 역학
- 촉진요인과 기회
- 만성질환 및 대사성 질환의 유병률 상승
- 급속한 고령화
- 억제요인과 과제
- 높은 제조 비용
- 촉진요인과 기회
- PESTEL 분석
- 펩티드 치료제 시장 동향
- 밸류체인 분석
제5장 세계의 펩티드 치료제 시장 : 유형별
- 주요 조사 결과
- 서론
- 제네릭
- 신약
제6장 세계의 펩티드 치료제 시장 : 제조업체 유형별
- 주요 조사 결과
- 서론
- 자사
- 외부 위탁
제7장 세계의 펩티드 치료제 시장 : 투여 경로별
- 주요 조사 결과
- 서론
- 비경구 경로
- 경구 경로
- 폐
- 점막
- 기타
제8장 세계의 펩티드 치료제 시장 : 합성 기술별
- 주요 조사 결과
- 서론
- 고상 펩티드 합성(SPPS)
- 재조합 DNA 기술
- 하이브리드 기술
- 액상 펩티드 합성(LPPS)
- 기타
제9장 세계의 펩티드 치료제 시장 : 용도별
- 주요 조사 결과
- 서론
- 암
- 대사장애
- 심혈관질환
- 호흡기질환
- 위장 장애
- 감염증
제10장 세계의 펩티드 치료제 시장 : 지역별
- 주요 조사 결과
- 서론
- 펩티드 치료제 시장 평가 : 지역별, 2020-2034년
- 북미
- 북미 : 유형별, 2020-2034년
- 북미 : 제조업체별, 2020-2034년
- 북미 : 투여 경로별, 2020-2034년
- 북미 : 합성 기술별, 2020-2034년
- 북미 : 용도별, 2020-2034년
- 미국
- 캐나다
- 유럽
- 유럽 : 유형별, 2020-2034년
- 유럽 : 제조업체별, 2020-2034년
- 유럽 : 투여 경로별, 2020-2034년
- 유럽 : 합성 기술별, 2020-2034년
- 유럽 : 용도별, 2020-2034년
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 유형별, 2020-2034년
- 아시아태평양 : 제조업체별, 2020-2034년
- 아시아태평양 : 투여 경로별, 2020-2034년
- 아시아태평양 : 합성 기술별, 2020-2034년
- 아시아태평양 : 용도별, 2020-2034년
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 유형별, 2020-2034년
- 중동 및 아프리카 : 제조업체별, 2020-2034년
- 중동 및 아프리카 : 투여 경로별, 2020-2034년
- 중동 및 아프리카 : 합성 기술별, 2020-2034년
- 중동 및 아프리카 : 용도별, 2020-2034년
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 유형별, 2020-2034년
- 라틴아메리카 : 제조업체별, 2020-2034년
- 라틴아메리카 : 투여 경로별, 2020-2034년
- 라틴아메리카 : 합성 기술별, 2020-2034년
- 라틴아메리카 : 용도별, 2020-2034년
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제11장 경쟁 구도
- 사업 확대·인수 분석
- 사업 확대
- 인수
- 제휴/협업/협정/공개
제12장 기업 개요
- Amgen Inc.
- AstraZeneca PLC
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd
- GSK plc(GlaxoSmithKline plc)
- Ipsen Pharma
- Ironwood Pharmaceuticals, Inc.
- Novartis AG
- Novo Nordisk A/S
- Pfizer Inc.
- Radius Health, Inc.
- Sanofi S.A.
The peptide therapeutics market size is expected to reach USD 313.33 Billion by 2034, according to a new study by Polaris Market Research. The report "Peptide Therapeutics Market Size, Share, Trends, & Industry Analysis Report By Type (Generic and Innovative), By Type of Manufacturers, By Route of Administration, By Synthesis Technology, By Application, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The peptide therapeutics market is evolving as pharmaceutical and biotechnology companies develop advanced formulations with improved stability, bioavailability, and delivery mechanisms. Growing improvements in peptide synthesis technologies and solid-phase manufacturing processes, lowered the production costs and expanded formulation options.
Additionally, regulatory agencies are facilitating the approval of novel peptide drugs through supportive frameworks, further accelerating the market growth. The growing portfolio of peptide-based products in the clinical pipeline and increasing commercialization activity are boosting market expansion across oncology, metabolic disorders, infectious diseases, and rare therapeutic areas.
Peptide Therapeutics Market Report Highlights
In terms of type, the innovative peptide therapeutics segment emerged as the market leader in revenue share during 2024 due its superior pharmacological properties and proven effectiveness in treating challenging conditions across oncology, metabolic disorders, and rare diseases.
In terms of type of manufacturers, the outsourced manufacturing segment is gaining momentum as biotech firms and specialty developers increasingly partner with CDMOs.
Based on route of administration, the parenteral route segment secured the largest revenue share in 2024, maintaining its position as the preferred delivery method for peptide-based treatments.
North America captured a dominant 60.21% share of the global peptide therapeutics market in 2024 due to the region's cutting-edge healthcare infrastructure, robust research capabilities, and comprehensive medical reimbursement frameworks.
The Asia Pacific peptide therapeutics market is poised to register the fastest CAGR during the forecast period due to increasing governmental support for biopharmaceutical innovation, with investments in domestic drug development.
A few global key market players include Advanced Accelerator Applications SA, AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, Bracco Imaging S.p.A., Cardinal Health, Inc., Curium Pharma, Eckert & Ziegler SE, F. Hoffmann-La Roche Ltd, GE HealthCare Technologies Inc., GlaxoSmithKline plc (GSK plc), Jubilant Radiopharma Limited, Lantheus Holdings, Inc., Eli Lilly and Company, and Mallinckrodt plc.
Polaris Market Research has segmented the market report on the basis of type, type of manufacturers, route of administration, synthesis technology, application, and region:
By Type Outlook (Revenue, USD Billion, 2020-2034)
Generic
Innovative
By Type of Manufacturers Outlook (Revenue, USD Billion, 2020-2034)
In-house
Outsourced
By Route of Administration Outlook (Revenue, USD Billion, 2020-2034)
Parenteral Route
Oral Route
Pulmonary
Mucosal
Others
By Synthesis Technology Outlook (Revenue, USD Billion, 2020-2034)
Solid Phase Peptide Synthesis (SPPS)
Recombinant DNA Technology
Hybrid Technology
Liquid-Phase Peptide Synthesis (LPPS)
Others
By Application Outlook (Revenue, USD Billion, 2020-2034)
Cancer
Metabolic Disorders
Cardiovascular Disorders
Respiratory Disorders
Gastrointestinal Disorders
Infectious Diseases
Pain
Dermatological Disorders
Neurological Disorders
Renal Disorders
Others
By Regional Outlook (Revenue, USD Billion, 2020-2034)
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Peptide Therapeutics Market Insights
- 4.1. Peptide Therapeutics Market - Market Snapshot
- 4.2. Peptide Therapeutics Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Prevalence of Chronic and Metabolic Diseases
- 4.2.1.2. Rapid Aging Population
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Manufacturing Costs
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Peptide Therapeutics Market Trends
- 4.6. Value Chain Analysis
5. Global Peptide Therapeutics Market, by Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 5.3. Generic
- 5.3.1. Global Peptide Therapeutics Market, by Generic, by Region, 2020-2034 (USD Billion)
- 5.4. Innovative
- 5.4.1.1. Global Peptide Therapeutics Market, by Innovative, by Region, 2020-2034 (USD Billion)
6. Global Peptide Therapeutics Market, by Type of Manufacturers
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
- 6.3. In-house
- 6.3.1. Global Peptide Therapeutics Market, by In-house, by Region, 2020-2034 (USD Billion)
- 6.4. Outsourced
- 6.4.1. Global Peptide Therapeutics Market, by Outsourced, by Region, 2020-2034 (USD Billion)
7. Global Peptide Therapeutics Market, by Route of Administration
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
- 7.3. Parenteral Route
- 7.3.1. Global Peptide Therapeutics Market, by Parenteral Route, by Region, 2020-2034 (USD Billion)
- 7.4. Oral Route
- 7.4.1. Global Peptide Therapeutics Market, by Oral Route, by Region, 2020-2034 (USD Billion)
- 7.5. Pulmonary
- 7.5.1. Global Peptide Therapeutics Market, by Pulmonary, by Region, 2020-2034 (USD Billion)
- 7.6. Mucosal
- 7.6.1. Global Peptide Therapeutics Market, by Mucosal, by Region, 2020-2034 (USD Billion)
- 7.7. Others
- 7.7.1. Global Peptide Therapeutics Market, by Others, by Region, 2020-2034 (USD Billion)
8. Global Peptide Therapeutics Market, by Synthesis Technology
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
- 8.3. Solid Phase Peptide Synthesis (SPPS)
- 8.3.1. Global Peptide Therapeutics Market, by Solid Phase Peptide Synthesis (SPPS), by Region, 2020-2034 (USD Billion)
- 8.4. Recombinant DNA Technology
- 8.4.1. Global Peptide Therapeutics Market, by Recombinant DNA Technology, by Region, 2020-2034 (USD Billion)
- 8.5. Hybrid Technology
- 8.5.1. Global Peptide Therapeutics Market, by Hybrid Technology, by Region, 2020-2034 (USD Billion)
- 8.6. Liquid-Phase Peptide Synthesis (LPPS)
- 8.6.1. Global Peptide Therapeutics Market, by Liquid-Phase Peptide Synthesis (LPPS), by Region, 2020-2034 (USD Billion)
- 8.7. Others
- 8.7.1. Global Peptide Therapeutics Market, by Others, by Region, 2020-2034 (USD Billion)
9. Global Peptide Therapeutics Market, by Application
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Global Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 9.3. Cancer
- 9.3.1. Global Peptide Therapeutics Market, by Cancer, by Region, 2020-2034 (USD Billion)
- 9.4. Metabolic Disorders
- 9.4.1. Global Peptide Therapeutics Market, by Metabolic Disorders, by Region, 2020-2034 (USD Billion)
- 9.5. Cardiovascular Disorders
- 9.5.1. Global Peptide Therapeutics Market, by Cardiovascular Disorders, by Region, 2020-2034 (USD Billion)
- 9.6. Respiratory Disorders
- 9.6.1. Global Peptide Therapeutics Market, by Respiratory Disorders, by Region, 2020-2034 (USD Billion)
- 9.7. Gastrointestinal Disorders
- 9.7.1. Global Peptide Therapeutics Market, by Gastrointestinal Disorders, by Region, 2020-2034 (USD Billion)
- 9.8. Infectious Diseases
- 9.8.1. Global Peptide Therapeutics Market, by Infectious Diseases, by Region, 2020-2034 (USD Billion)
10. Global Peptide Therapeutics Market, by Geography
- 10.1. Key Findings
- 10.2. Introduction
- 10.2.1. Peptide Therapeutics Market Assessment, By Geography, 2020-2034 (USD Billion)
- 10.3. Peptide Therapeutics Market - North America
- 10.3.1. North America: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 10.3.2. North America: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
- 10.3.3. North America: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.3.4. North America: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
- 10.3.5. North America: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 10.3.6. Peptide Therapeutics Market - U.S.
- 10.3.6.1. U.S.: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 10.3.6.2. U.S.: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
- 10.3.6.3. U.S.: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.3.6.4. U.S.: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
- 10.3.6.5. U.S.: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 10.3.7. Peptide Therapeutics Market - Canada
- 10.3.7.1. Canada: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 10.3.7.2. Canada: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
- 10.3.7.3. Canada: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.3.7.4. Canada: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
- 10.3.7.5. Canada: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 10.4. Peptide Therapeutics Market - Europe
- 10.4.1. Europe: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 10.4.2. Europe: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
- 10.4.3. Europe: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.4.4. Europe: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
- 10.4.5. Europe: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 10.4.6. Peptide Therapeutics Market - UK
- 10.4.6.1. UK: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 10.4.6.2. UK: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
- 10.4.6.3. UK: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.4.6.4. UK: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
- 10.4.6.5. UK: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 10.4.7. Peptide Therapeutics Market - France
- 10.4.7.1. France: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 10.4.7.2. France: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
- 10.4.7.3. France: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.4.7.4. France: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
- 10.4.7.5. France: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 10.4.8. Peptide Therapeutics Market - Germany
- 10.4.8.1. Germany: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 10.4.8.2. Germany: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
- 10.4.8.3. Germany: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.4.8.4. Germany: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
- 10.4.8.5. Germany: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 10.4.9. Peptide Therapeutics Market - Italy
- 10.4.9.1. Italy: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 10.4.9.2. Italy: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
- 10.4.9.3. Italy: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.4.9.4. Italy: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
- 10.4.9.5. Italy: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 10.4.10. Peptide Therapeutics Market - Spain
- 10.4.10.1. Spain: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 10.4.10.2. Spain: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
- 10.4.10.3. Spain: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.4.10.4. Spain: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
- 10.4.10.5. Spain: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 10.4.11. Peptide Therapeutics Market - Netherlands
- 10.4.11.1. Netherlands: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 10.4.11.2. Netherlands: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
- 10.4.11.3. Netherlands: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.4.11.4. Netherlands: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
- 10.4.11.5. Netherlands: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 10.4.12. Peptide Therapeutics Market - Russia
- 10.4.12.1. Russia: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 10.4.12.2. Russia: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
- 10.4.12.3. Russia: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.4.12.4. Russia: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
- 10.4.12.5. Russia: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 10.4.13. Peptide Therapeutics Market - Rest of Europe
- 10.4.13.1. Rest of Europe: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 10.4.13.2. Rest of Europe: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
- 10.4.13.3. Rest of Europe: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.4.13.4. Rest of Europe: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
- 10.4.13.5. Rest of Europe: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 10.5. Peptide Therapeutics Market - Asia Pacific
- 10.5.1. Asia Pacific: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 10.5.2. Asia Pacific: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
- 10.5.3. Asia Pacific: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.5.4. Asia Pacific: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
- 10.5.5. Asia Pacific: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 10.5.6. Peptide Therapeutics Market - China
- 10.5.6.1. China: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 10.5.6.2. China: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
- 10.5.6.3. China: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.5.6.4. China: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
- 10.5.6.5. China: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 10.5.7. Peptide Therapeutics Market - India
- 10.5.7.1. India: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 10.5.7.2. India: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
- 10.5.7.3. India: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.5.7.4. India: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
- 10.5.7.5. India: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 10.5.8. Peptide Therapeutics Market - Malaysia
- 10.5.8.1. Malaysia: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 10.5.8.2. Malaysia: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
- 10.5.8.3. Malaysia: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.5.8.4. Malaysia: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
- 10.5.8.5. Malaysia: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 10.5.9. Peptide Therapeutics Market - Japan
- 10.5.9.1. Japan: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 10.5.9.2. Japan: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
- 10.5.9.3. Japan: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.5.9.4. Japan: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
- 10.5.9.5. Japan: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 10.5.10. Peptide Therapeutics Market - Indonesia
- 10.5.10.1. Indonesia: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 10.5.10.2. Indonesia: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
- 10.5.10.3. Indonesia: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.5.10.4. Indonesia: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
- 10.5.10.5. Indonesia: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 10.5.11. Peptide Therapeutics Market - South Korea
- 10.5.11.1. South Korea: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 10.5.11.2. South Korea: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
- 10.5.11.3. South Korea: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.5.11.4. South Korea: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
- 10.5.11.5. South Korea: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 10.5.12. Peptide Therapeutics Market - Australia
- 10.5.12.1. Australia: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 10.5.12.2. Australia: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
- 10.5.12.3. Australia: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.5.12.4. Australia: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
- 10.5.12.5. Australia: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 10.5.13. Peptide Therapeutics Market - Rest of Asia Pacific
- 10.5.13.1. Rest of Asia Pacific: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 10.5.13.2. Rest of Asia Pacific: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
- 10.5.13.3. Rest of Asia Pacific: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.5.13.4. Rest of Asia Pacific: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
- 10.5.13.5. Rest of Asia Pacific: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 10.6. Peptide Therapeutics Market - Middle East & Africa
- 10.6.1. Middle East & Africa: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 10.6.2. Middle East & Africa: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
- 10.6.3. Middle East & Africa: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.6.4. Middle East & Africa: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
- 10.6.5. Middle East & Africa: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 10.6.6. Peptide Therapeutics Market - Saudi Arabia
- 10.6.6.1. Saudi Arabia: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 10.6.6.2. Saudi Arabia: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
- 10.6.6.3. Saudi Arabia: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.6.6.4. Saudi Arabia: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
- 10.6.6.5. Saudi Arabia: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 10.6.7. Peptide Therapeutics Market - UAE
- 10.6.7.1. UAE: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 10.6.7.2. UAE: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
- 10.6.7.3. UAE: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.6.7.4. UAE: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
- 10.6.7.5. UAE: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 10.6.8. Peptide Therapeutics Market - Israel
- 10.6.8.1. Israel: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 10.6.8.2. Israel: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
- 10.6.8.3. Israel: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.6.8.4. Israel: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
- 10.6.8.5. Israel: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 10.6.9. Peptide Therapeutics Market - South Africa
- 10.6.9.1. South Africa: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 10.6.9.2. South Africa: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
- 10.6.9.3. South Africa: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.6.9.4. South Africa: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
- 10.6.9.5. South Africa: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 10.6.10. Peptide Therapeutics Market - Rest of Middle East & Africa
- 10.6.10.1. Rest of Middle East & Africa: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 10.6.10.2. Rest of Middle East & Africa: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
- 10.6.10.3. Rest of Middle East & Africa: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.6.10.4. Rest of Middle East & Africa: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
- 10.6.10.5. Rest of Middle East & Africa: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 10.7. Peptide Therapeutics Market - Latin America
- 10.7.1. Latin America: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 10.7.2. Latin America: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
- 10.7.3. Latin America: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.7.4. Latin America: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
- 10.7.5. Latin America: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 10.7.6. Peptide Therapeutics Market - Mexico
- 10.7.6.1. Mexico: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 10.7.6.2. Mexico: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
- 10.7.6.3. Mexico: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.7.6.4. Mexico: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
- 10.7.6.5. Mexico: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 10.7.7. Peptide Therapeutics Market - Brazil
- 10.7.7.1. Brazil: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 10.7.7.2. Brazil: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
- 10.7.7.3. Brazil: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.7.7.4. Brazil: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
- 10.7.7.5. Brazil: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 10.7.8. Peptide Therapeutics Market - Argentina
- 10.7.8.1. Argentina: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 10.7.8.2. Argentina: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
- 10.7.8.3. Argentina: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.7.8.4. Argentina: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
- 10.7.8.5. Argentina: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 10.7.9. Peptide Therapeutics Market - Rest of Latin America
- 10.7.9.1. Rest of Latin America: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 10.7.9.2. Rest of Latin America: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
- 10.7.9.3. Rest of Latin America: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.7.9.4. Rest of Latin America: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
- 10.7.9.5. Rest of Latin America: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
11. Competitive Landscape
- 11.1. Expansion and Acquisition Analysis
- 11.1.1. Expansion
- 11.1.2. Acquisitions
- 11.2. Partnerships/Collaborations/Agreements/Exhibitions
12. Company Profiles
- 12.1. Amgen Inc.
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Benchmarking
- 12.1.4. Recent Development
- 12.2. AstraZeneca PLC
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Benchmarking
- 12.2.4. Recent Development
- 12.3. Eli Lilly and Company
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Benchmarking
- 12.3.4. Recent Development
- 12.4. F. Hoffmann-La Roche Ltd
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Benchmarking
- 12.4.4. Recent Development
- 12.5. GSK plc (GlaxoSmithKline plc)
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Benchmarking
- 12.5.4. Recent Development
- 12.6. Ipsen Pharma
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Benchmarking
- 12.6.4. Recent Development
- 12.7. Ironwood Pharmaceuticals, Inc.
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Benchmarking
- 12.7.4. Recent Development
- 12.8. Novartis AG
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Benchmarking
- 12.8.4. Recent Development
- 12.9. Novo Nordisk A/S
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Benchmarking
- 12.9.4. Recent Development
- 12.10. Pfizer Inc.
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Benchmarking
- 12.10.4. Recent Development
- 12.11. Radius Health, Inc.
- 12.11.1. Company Overview
- 12.11.2. Financial Performance
- 12.11.3. Product Benchmarking
- 12.11.4. Recent Development
- 12.12. Sanofi S.A.
- 12.12.1. Company Overview
- 12.12.2. Financial Performance
- 12.12.3. Product Benchmarking
- 12.12.4. Recent Development
샘플 요청 목록